385 related articles for article (PubMed ID: 27807473)
21. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
22. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.
Islam MR; Rauf A; Akash S; Trisha SI; Nasim AH; Akter M; Dhar PS; Ogaly HA; Hemeg HA; Wilairatana P; Thiruvengadam M
Biomed Pharmacother; 2024 Jan; 170():116034. PubMed ID: 38141282
[TBL] [Abstract][Full Text] [Related]
24. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma.
Zanotto-Filho A; Braganhol E; Edelweiss MI; Behr GA; Zanin R; Schröder R; Simões-Pires A; Battastini AM; Moreira JC
J Nutr Biochem; 2012 Jun; 23(6):591-601. PubMed ID: 21775121
[TBL] [Abstract][Full Text] [Related]
25. Curcumin's spice-infused therapeutic promise: disease severity alleviation in a mouse model of multiple sclerosis via modulation of immune responses.
Amiri Z; Jalili S; Tarahomi M; Eslami M; Yazdanpanah E; Baharlou R; Esmaeili SA; Yousefi B; Haghmorad D
Mol Biol Rep; 2023 Nov; 50(11):8843-8853. PubMed ID: 37660318
[TBL] [Abstract][Full Text] [Related]
26. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.
Mahran RI; Hagras MM; Sun D; Brenner DE
AAPS J; 2017 Jan; 19(1):54-81. PubMed ID: 27783266
[TBL] [Abstract][Full Text] [Related]
27. Curcumin and neurodegenerative diseases: a perspective.
Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
[TBL] [Abstract][Full Text] [Related]
28. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Kunnumakkara AB; Anand P; Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
[TBL] [Abstract][Full Text] [Related]
29. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
30. New Promising Therapeutic Avenues of Curcumin in Brain Diseases.
Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
32. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
33. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
[TBL] [Abstract][Full Text] [Related]
34. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art.
Zangui M; Atkin SL; Majeed M; Sahebkar A
Pharmacol Res; 2019 Mar; 141():343-356. PubMed ID: 30641277
[TBL] [Abstract][Full Text] [Related]
35. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.
Goel A; Aggarwal BB
Nutr Cancer; 2010; 62(7):919-30. PubMed ID: 20924967
[TBL] [Abstract][Full Text] [Related]
36. Challenges associated with curcumin therapy in Alzheimer disease.
Belkacemi A; Doggui S; Dao L; Ramassamy C
Expert Rev Mol Med; 2011 Nov; 13():e34. PubMed ID: 22051121
[TBL] [Abstract][Full Text] [Related]
37. Role of Autophagy on Heavy Metal-Induced Renal Damage and the Protective Effects of Curcumin in Autophagy and Kidney Preservation.
Avila-Rojas SH; Lira-León A; Aparicio-Trejo OE; Reyes-Fermín LM; Pedraza-Chaverri J
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31295875
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of curcumin.
Sharma RA; Steward WP; Gescher AJ
Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
[TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Curcumin against Lipopolysaccharide-Induced Toxicity.
Ganji A; Farahani I; Saeedifar AM; Mosayebi G; Ghazavi A; Majeed M; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2021 Oct; 28(33):6915-6930. PubMed ID: 34036908
[TBL] [Abstract][Full Text] [Related]
40. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.
Mudduluru G; George-William JN; Muppala S; Asangani IA; Kumarswamy R; Nelson LD; Allgayer H
Biosci Rep; 2011 Jun; 31(3):185-97. PubMed ID: 20815812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
